Rhythm Biosciences Ltd has released a press release.
RHY Genetype Commercial Sales
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- RHY Investor Webinar
- Genetype Commercial Integration Completion
- Quarterly Activities Report and Appendix 4C - Dec24
- About the Genetype Acquisition
- Completion of Genetype Risk Assessment Portfolio Acquisition
Later from Rhythm Biosciences
- EGM - Investor Presentation
- Quarterly Activities Report and Appendix 4C 31 March 2025
- Breast Cancer Risk Study University of Melbourne
- ColoSTAT Beta kit verification and validation update
- NATA Accreditation Awarded for Genetype Laboratory
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences